Quiz: Recent Advances in Menopause and Midlife Women’s Health Research

New clinical research presented at The Menopause Society’s 2025 Annual Meeting highlighted menopausal hormone therapy (MHT), from its potential neuroprotective effects to its impact on weight management and cardiovascular health.

Do you know how the timing of hormone therapy may influence Alzheimer’ disease biomarkers? Or what recent studies found about combining hormone therapy with tirzepatide, the dual GLP-1/GIP agonist that’s transforming obesity care? How about the latest phase 3 evidence on estetrol, a selective estrogen receptor modulator with no impact on blood pressure—even in women at elevated cardiovascular risk?

Put your knowledge to the test in this quick, 6-question quiz that highlights findings from 4 new studies presented at the annual meeting. Whether you are managing midlife women in your practice or simply staying current with women’s health science, see how your understanding stacks up against the latest evidence.

Every question in this quiz is drawn from recent coverage on Patient Care. Revisit the full articles for deeper insight into the data, study design, and implications for primary care practice:

• MHT and Alzheimer Risk: New Evidence for a Critical Window (with Roksana Karim, MD, PhD)
• Mayo Clinic Researcher on How Hormone Therapy May Influence Weight-Loss Outcomes with Tirzepatide
• Estetrol Phase 3 Trial Shows No Impact on Postmenopausal BP, Even in Women at High CV Risk
• Menopause Education Wholly Inadequate for Physician Associates, According to New Survey Results